French & Swiss Scientists Demonstrate ‘All-in-One’ Technique that Could Accelerate Phage-Therapy Diagnosis
Members, MEDICALPSLensless Imaging System Affirms Phage Therapy's Value in Treating Serious Infection, Tracks Phage Resistance and Could Easily Be Implemented in Compact Devices at Phage Labs
GRENOBLE, France – April 13, 2021 – A team of French and Swiss…
Koelis announces first procedures in 3D fusion imaging-guided focal ablation of prostate cancer in its clinical study VIOLETTE
Members, MEDICALPSMEYLAN, France, April 8th, 2021 – KOELIS, an international leader in prostate fusion imaging, announces enrolling the first patients in the VIOLETTE clinical trial (NCT04582656) on 3D fusion imaging-guided focal ablation of prostate cancer.
Prostate…
Targeting Cancer Detection & Identification of Microorganisms, CEA-Leti Develops Mid-Infrared, Spectral-Imaging Technique
Members, MEDICALPSPresentations at Photonics West 2021 Show How Early-Stage Imaging System’s Flexibility Can Be Applied Broadly in Medical Field
GRENOBLE, France – March 18, 2021 – CEA-Leti scientists have developed a lensless, infrared spectral-imaging…
WHITE PAPER: a game-changing preclinical testing model for synergistic immuno-oncology drug candidates
Members, MEDICALPSInovotion is a Contract Research Laboratory implementing a unique approach to in vivo evaluation for anticancer drug discovery.
As a Contract Research Organisation (CRO) that is dedicated to in vivo evaluation for drug discovery, particularly…
Vulkalloys® machining: A partnership between Vulkam and LAMPA*.
MEDICALPS, MembersVULKAM is strengthening its R&D activities in the field of Amorphous Metal Alloys in order to develop the industrial solutions of tomorrow, especially dedicated to Medtechs, by relying on leading French laboratories such as LAMPA.
The…
Stéphane Altaba is appointed CEO of the start-up company LXRepair
Members, MEDICALPS
Stéphane Altaba, with extensive experience in biotechnology companies, becomes CEO of LXRepair
He will lead the commercial launch of Safer Rad-LX®, the first predictive test on toxicity of radiotherapy treatments, and he is expected…
CEA-Leti Reports Machine-Learning Breakthrough That Opens Way to Edge Learning
Members, MEDICALPSArticle in Nature Electronics Details Method that Takes Advantage of RRAM Non-Idealities
To Create Intelligent Systems that Have Potential Medical-Diagnostic Applications
GRENOBLE, France – Jan. 19, 2021 – CEA-Leti scientists…
L’écosystème Santé représenté par MEDICALPS à l’honneur !
MEDICALPSLe 19 janvier 2021, Gregory VERNIER présentait aux étudiants en Master de Grenoble Ecole de Management l'écosystème Santé représenté par MEDICALPS sur le sillon alpin !
Lancé par l'Ecole grenobloise de Management, l'événement "Entrepreneurship…
Scaljet & Microdatec-Saphintec Strategic Partnership
Members, MEDICALPSWe are delighted to announce that in line with our Strategic & Development Plan, Scaljet has signed an exclusive R&D Partnership Agreement with Microdatec-Saphintec for the development, miniaturization and production of its patented…
NH TherAguix announces FDA acceptance of IND to initiate clinical trials in the USA
MEDICALPS, MembersMeylan - November 16th, 2020
NH TherAguix (“NHT”) today announces that the U.S. Food and Drug Administration ("FDA") has accepted the company's Investigational New Drug Application ("IND") for its drug candidate AGuIX to be combined with…